Agenus

Agenus is a clinical-stage immuno-oncology company dedicated to discovering and developing therapies that harness the human immune system to fight cancer. The company’s vision is to expand the population of patients benefiting from cancer immunotherapies by employing multiple combination approaches that leverage a broad range of antibody therapies and proprietary cancer vaccine platforms. Equipped with a suite of antibody discovery platforms and state-of-the-art GMP manufacturing facilities, the company is well-positioned to support pre-commercial clinical programs.